A vaccine that could offer protection against COVID-19 and the flu has received positive results during trials.According to the drug maker, Moderna the shot called mRNA-1083 showed encouraging results among older adults. The trial for the dual-purpose vaccine involved more…
Tag: Trial
Once-weekly insulin icodec with dosing guide app showed superior HbA1c reduction versus once-daily insulin in phase 3a trial
In the Phase 3a ONWARDS 5 randomized trial, once-weekly insulin icodec titrated with a dosing guide app demonstrated superior reduction in HbA1c levels and similarly low hypoglycemia rates compared with once-daily insulin. The findings are published in Annals of Internal Medicine.
New Potential Therapy for Fatty Liver Disease
In a subset of patients with partial lipodystrophy and/or NASH, the hormone leptin can be leveraged as a therapeutic agent to move fat out of the liver.
Lifestyle Improvement Program Found to Increase Physical Activity
Researchers at the Rush Institute of Healthy Aging have found that D-CLIP, a lifestyle education program to prevent diabetes in South Asians with prediabetes increased physical activity by nearly an hour a week.
ACTG Announces Launch of Novel Clinical Trial Testing Multiple Therapeutics to Treat COVID-19
The AIDS Clinical Trials Group (ACTG) has initiated the ACTIV-2 Outpatient Monoclonal Antibodies and Other Therapies Trial. ACTIV-2 includes both phase 2 and phase 3 evaluations of multiple promising investigational agents for treating early COVID-19 in a single trial.